Frailty is a critical determinant of outcomes in patients with cirrhosis. In this webinar we will present practical methods to assess and quantify frailty in both the outpatient and inpatient clinical settings. We will also provide recommendations on specific interventions once frailty is identified.
Jennifer Lai, MD
Dr. Lai is a transplant hepatologist, on faculty at the University of California, San Francisco. Her long-term mission is to help patients with end-stage liver disease survive to and thrive after liver transplantation. Her primary research focuses on integrating core geriatric principles, such as frailty and physical function, into the day-to-day practice of hepatology and transplant medicine to improve the care of her patients.
She is the founder and principal investigator of the Functional Assessment in Liver Transplantation (FrAILT) Study, a multi-center collaboration aimed at investigating the impact of frailty on liver transplant outcomes. For her work, she has been named a Beeson Scholar in Aging Research by the National Institute on Aging and a Top 40 Under 40 Leader by the San Francisco Business Times.
Puneeta Tandon, MD, FRCPC
Dr. Tandon is an Associate Professor of Medicine, Director of the Cirrhosis Care Clinic and transplant hepatologist at the University of Alberta in Edmonton, Alberta, Canada. She completed her gastroenterology and hepatology training at the University of Alberta with fellowships at Yale University and the Hospital Clinic in Barcelona.
Her clinical practice and research are focused on cirrhosis. Research interests include acute on chronic liver failure and its related complications, sarcopenia, frailty, nutrition, exercise therapy and the early integration of palliative care principles in cirrhosis.
Jody Olson, MD
Dr. Jody Olson is currently an Assistant Professor in the departments of Internal Medicine and Surgery at the University of Kansas Medical Center and is primarily affiliated with the liver transplant program. His clinical interests are centered on caring for patients with advanced liver disease in the inpatient and intensive care setting.
His research is focused on the critically ill liver disease patient, both acute and chronic and works in the area of acute-on-chronic liver failure. In addition, he is the site primary investigator for the NIH sponsored United States Acute Liver Failure Study Group at the University of Kansas.
Elliot Tapper, MD
Dr. Elliot Tapper is Assistant Professor of Medicine at the University of Michigan Health System. Dr. Tapper’s research aims to improve the outcomes, quality of life and freedom from adverse events for patients with decompensated cirrhosis. His efforts focus on delineating quality indicators and developing interventions for the management and prevention of cirrhotic complications.